Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Current Leases (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Current Leases data on record, last reported at $167000.0 in Q4 2025.

  • For Q4 2025, Current Leases fell 22.69% year-over-year to $167000.0; the TTM value through Dec 2025 reached $167000.0, down 22.69%, while the annual FY2025 figure was $167000.0, 22.69% down from the prior year.
  • Current Leases reached $167000.0 in Q4 2025 per TLSI's latest filing, up from $129000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $379000.0 in Q3 2023 and bottomed at $118000.0 in Q1 2025.
  • Average Current Leases over 4 years is $255000.0, with a median of $266000.0 recorded in 2024.
  • Peak YoY movement for Current Leases: decreased 5.14% in 2023, then tumbled 67.49% in 2025.
  • A 4-year view of Current Leases shows it stood at $370000.0 in 2022, then dropped by 5.14% to $351000.0 in 2023, then tumbled by 38.46% to $216000.0 in 2024, then fell by 22.69% to $167000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $167000.0 in Q4 2025, $129000.0 in Q3 2025, and $123000.0 in Q2 2025.